The fragmentation of the mental health care system creates daily clinical hazards for patients with schizophrenia, according to Michael McGuire, PharmD, BCPP, professor of pharmacy practice at Belmont University College of Pharmacy and Health Sciences, in an interview with Pharmacy Times.
Practicing at a freestanding behavioral health hospital disconnected from larger health system records, McGuire routinely treats patients whose medication histories are incomplete or inaccessible. Without a shared electronic health record, determining whether a patient is already on an LAI, and when their last dose was administered, requires multiple phone calls to pharmacies and outpatient clinics, and still may yield no answer if a patient lacks a fixed address. The result can be dangerous duplication: patients inadvertently receiving two different LAIs or double-dosed on the same agent.
Key Takeaways
- Fragmented electronic health records and incomplete medication histories make it dangerously difficult to track LAI administration across care settings.
- Pharmacists offer a uniquely holistic view of a patient's medication regimen and are well-positioned to serve as a bridge among prescribers, payers, and care sites.
- Without Medicare provider status and clear reimbursement pathways, pharmacists' ability to deliver and bill for care coordination, LAI administration, and outpatient psychiatric services remains severely limited.
McGuire makes a forceful case for integrating pharmacists into mental health care teams, arguing that pharmacists offer a uniquely comprehensive view of a patient's full medication regimen. He describes catching a potentially life-threatening cardiac medication omission during a recent hospital admission — an error that a pharmacist's involvement in medication reconciliation caught before harm occurred. If he could choose one systemic change, he says, it would be placing a pharmacist on every mental health team.
Realizing that vision, however, requires policy reform. Pharmacists are not recognized as providers under Medicare, limiting reimbursement for care coordination, outpatient clinic services, and LAI administration. McGuire envisions a national registry for LAIs — analogous to controlled substance monitoring programs — that could prevent medication errors and support adherence tracking across care settings. Until provider status and reimbursement pathways are addressed, he argues, pharmacists' capacity to improve mental health outcomes will remain artificially constrained.
